Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06507930

The COMPASSION Study

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Detailed description

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams. Study procedures include giving verbal consent to participate and a one-time survey delivered by email or phone call. About 200 people, which includes 50 participants, 50 caregivers, 50 hospice nurses, and about 50 oncology providers, are expected to participate in this research study.

Conditions

Interventions

TypeNameDescription
OTHERTelehealth Hospice VisitsTelehealth check-in appointments with oncology care team, MD, PA, NP, or hospice nurse, via HIPAA compliant telehealth platform, Zoom, or by phone call.

Timeline

Start date
2024-09-01
Primary completion
2026-10-01
Completion
2027-03-01
First posted
2024-07-18
Last updated
2025-10-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06507930. Inclusion in this directory is not an endorsement.

The COMPASSION Study (NCT06507930) · Clinical Trials Directory